LESLIE LESOON: Open Payments
NPI 1932571684 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 36 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $899
Food & beverage: $799Education: $100
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $170 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| ABBVIE INC. | 9 | $142 |
| Astellas Pharma US Inc | 2 | $133 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Novo Nordisk Inc | 3 | $64 |
| PFIZER INC. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Dexcom, Inc. | 1 | $18 |
Products named: AIRSUPRA, QULIPTA, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE, Veozah, SPRAVATO, Ozempic.
Industry payments across PA — which companies pay providers there.
